Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children
复制标题
DOI:
10.1542/peds.2007-1578
复制
发表时间:
2008-03-01
期刊:
影响因子:
8
通讯作者:
Davis, Robert
中科院分区:
文献类型:
--
作者:
France, Eric K.;Glanz, Jason;Davis, Robert
BACKGROUND. The measles-mumps-rubella vaccine has been associated with immune thrombocytopenia purpura in 2 small studies.METHODS. By using the Vaccine Safety Datalink, we identified measles-mumps-rubella vaccinated children aged 1 to 18. A case of immune thrombocytopenia purpura was defined as a patient with a platelet count of